Abstract
Background: Travel to international mass gatherings such as the Hajj pilgrimage increases the risk of Neisseria meningitidis transmission and meningococcal disease. We investigated carriage and acquisition of N. meningitidis among travelers to Hajj and determined circulating serogroups, sequence types and antibiotic susceptibility among isolates. Method: We conducted a multinational longitudinal cohort study among 3921 traveling pilgrims in two phases: Pre-Hajj and Post-Hajj. For each participant, a questionnaire was administered and an oropharyngeal swab was obtained. N. meningitidis was isolated, serogrouped, and subjected to whole genome sequence analysis and antibiotic susceptibility testing. Results: Overall carriage and acquisition rates of N. meningitidis were 0.74% (95%CI: 0.55–0.93) and 1.10% (95%CI: 0.77–1.42) respectively. Carriage was significantly higher Post-Hajj (0.38% vs 1.10%, p = 0.0004). All isolates were nongroupable, and most belonged to the ST-175 complex and were resistant to ciprofloxacin with reduced susceptibility to penicillins. Three potentially invasive isolates (all genogroup B) were identified in the Pre-Hajj samples. No factors were associated with Pre-Hajj carriage. Suffering influenza like illness symptoms and sharing a room with >15 people were associated with lower carriage Post-Hajj (adjOR = 0.23; p = 0.008 and adjOR = 0.27; p = 0.003, respectively). Conclusion: Carriage of N. meningitidis among traveler attending Hajj was low. However, most isolates were resistant to ciprofloxacin used for chemoprophylaxis. A review of the current meningococcal disease preventive measures for Hajj is warranted.
Original language | English |
---|---|
Article number | 102581 |
Journal | Travel Medicine and Infectious Disease |
Volume | 53 |
DOIs | |
Publication status | Published - 1 May 2023 |
Bibliographical note
Funding Information:This work was supported by Pfizer Pharmaceuticals (grant number WI224461 ).
Funding Information:
This publication made use of the Neisseria Multi Locus Sequence Typing website ( https://pubmlst.org/organisms/neisseria-spp/ ) sited at the University of Oxford. The development of this site has been funded by the Wellcome Trust and European Union . The authors would like to thank James Bray (University of Oxford) for assembling the draft genomes and depositing them on the PubMLST Neisseria database and for depositing the raw reads on the European Nucleotide Archive.
Funding Information:
This work was supported by Pfizer Pharmaceuticals (grant number WI224461).This publication made use of the Neisseria Multi Locus Sequence Typing website (https://pubmlst.org/organisms/neisseria-spp/) sited at the University of Oxford. The development of this site has been funded by the Wellcome Trust and European Union. The authors would like to thank James Bray (University of Oxford) for assembling the draft genomes and depositing them on the PubMLST Neisseria database and for depositing the raw reads on the European Nucleotide Archive.
Publisher Copyright:
© 2023 The Author(s)
Keywords
- Antibiotic resistance
- Mass gatherings
- Meningococcal disease
- Public health
- Travel
- Vaccine